EP3309263
BIOMARKERS ASSOCIATED WITH CDK INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.6.2013EP published:
25.12.2019EP application number:
17198700.1
EPO information:
European Patent Register
Max expiry date:
25.6.2033
Title:
BIOMARKERS ASSOCIATED WITH CDK INHIBITORS
Timeline
Today
26.6.2013EP application
25.12.2019EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, Boston, MA 02215-5450, US
Name:
Broad InstituteAddress:
44 Binney Street, Boston, Massachusetts 02115, US
Inventor
Name:
CAPONIGRO, GiordanoAddress:
Cambridge, MA 02139, US
Name:
DELACH, ScottAddress:
Cambridge, MA 02139, US
Name:
GARRAWAY, LeviAddress:
Boston, MA 02215-5450, US
Name:
JAGANI, ZainabAddress:
Cambridge, MA 02139, US
Name:
KIM, SunkyuAddress:
Cambridge, MA 02139, US
Name:
KRYUKOV, GregoryAddress:
Cambridge, MA 02143, US
Priority
Number:
201261669534 PDate:
9.7.2012Country:
US
Classification
Categories:
C12Q 1/6886, A61K 31/454, A61K 31/506, A61K 31/519, G01N 33/50, G01N 33/574